Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA grants orphan drug status to rosuvastatin calcium in pediatric HoFH

Feb. 18, 2014

Canadian researchers design novel MAbs to human GnRH receptor

Feb. 18, 2014

FDA approves BioMarin's Vimizim for MPS IVA

Feb. 17, 2014

Novel GPR119 receptor agonists patented

Feb. 17, 2014

Sato Pharmaceutical discloses new SLC22A12 inhibitors

Feb. 17, 2014

Preclinical characterization of a novel N-glucoside SGLT2 inhibitor

Feb. 17, 2014

Lilly describes nonsteroidal glucocorticoid antagonist that minimizes treatment-related weight gain

Feb. 14, 2014

Bayer completes decentralized registration procedure in E.U. for low-dose contraceptive patch

Feb. 13, 2014

Biodel reports preliminary results from phase I trial of concentrated insulin BIOD-531

Feb. 13, 2014

Merck & Co. discloses novel DPP IV inhibitors

Feb. 13, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...